02.06.2016 09:05:00
|
Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa
Illumina, Inc. (NASDAQ: ILMN) today announced that it has appointed Paula Dowdy to lead the Europe, Middle East and Africa (EMEA) commercial team as Senior Vice President and General Manager. Paula was previously Senior Vice President for Cloud, Software, and Managed Services at Cisco.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160602005365/en/

Paula Dowdy (Photo: Business Wire)
"We are truly excited for Paula to lead our EMEA commercial operations team,” said Christian Henry, Executive Vice President for Commercial Operations. "Paula brings a proven track record of leadership, insight and execution, and her passion for delivering customer success will serve the EMEA region exceptionally well. Additionally, this hire supports our strategy to bring in expertise from large-scale companies to complement our leadership team.”
Paula joined Cisco 20 years ago and has spent the majority of her career in Europe. She has held numerous senior positions leading Cisco product and services groups for virtually all customer segments. In her most recent role, Paula led Cisco’s go-to-market team for Cloud, Software, and Managed Services where she drove the incubation of innovative new solutions.
Paula holds an MBA degree from Pepperdine University and a Bachelor of Arts degree from the University of California, Berkeley. Paula will officially join Illumina August 1, 2016.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160602005365/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Illumina Inc.mehr Nachrichten
10.02.25 |
Börse New York: S&P 500 liegt schlussendlich im Plus (finanzen.at) | |
10.02.25 |
Starker Wochentag in New York: S&P 500 verbucht Gewinne (finanzen.at) | |
10.02.25 |
Aufschläge in New York: Börsianer lassen S&P 500 am Montagmittag steigen (finanzen.at) | |
10.02.25 |
Handel in New York: S&P 500 bewegt sich zum Start im Plus (finanzen.at) | |
07.02.25 |
NYSE-Handel S&P 500 notiert letztendlich im Minus (finanzen.at) | |
07.02.25 |
Börse New York: S&P 500 verliert nachmittags (finanzen.at) | |
07.02.25 |
Zurückhaltung in New York: S&P 500 fällt (finanzen.at) | |
07.02.25 |
Zurückhaltung in New York: S&P 500 gibt zum Handelsstart nach (finanzen.at) |
Analysen zu Illumina Inc.mehr Analysen
Aktien in diesem Artikel
Illumina Inc. | 96,26 | -0,35% |
|